.Pharmacolibrary.Drugs.R_RespiratorySystem.R05D_CoughSuppressantsExclCombinationsWithExpectorant.R05DB11_Pipazetate.Pipazetate .Pharmacolibrary.Drugs.R_RespiratorySystem.R05D_CoughSuppressantsExclCombinationsWithExpectorant.R05DB11_Pipazetate.Pipazetate| name: | Pipazetate | |
| ATC code: | R05DB11 | route: | oral |
| compartments: | 1 | |
| dosage: | 30 | mg |
| volume of distribution: | 2.5 | L |
| clearance: | 10 | mL/min/kg |
| other parameters in model implementation | ||
Pipazetate is an antitussive (cough suppressant) agent, previously used in several countries for the treatment of non-productive cough. It is a phenothiazine derivative with a central action on cough reflex. The drug is rarely used or approved today and has limited availability in many countries.
No published pharmacokinetic studies or parameter reports for pipazetate in humans found in the scientific literature up to 2024. Most information is based on limited data from drug monographs and class-based estimations.